You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Familial Hypercholesterolemia - Heterozygous

Showing 1 - 25 of 1,491
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypercholesterolemia, Familial Hypercholesterolemia Trial (MK-0616, Placebo)

Not yet recruiting
  • Hypercholesterolemia
  • Familial Hypercholesterolemia
  • (no location specified)
Jul 10, 2023

Familial Hypercholesterolemia - Heterozygous Trial in Paris (CAC Score)

Completed
  • Familial Hypercholesterolemia - Heterozygous
  • CAC Score
  • Paris, France
    Hôpital Pitié-Salpêtrière
Sep 9, 2021

Hypercholesterolemia, Familial, Hypercholesterolemia, Familial, 1, Hypercholesterolemia, Familial, 2 Trial in Moscow (genetic,

Recruiting
  • Hypercholesterolemia, Familial
  • +25 more
  • Genetic Testing
  • +7 more
  • Moscow, Russian Federation
    National Medical Research Centre for Therapy and Preventive Medi
Jul 25, 2022

Familial Hypercholesterolemia, Familial Hypercholesterolemia Due to Genetic Defect of Apolipoprotein B, Familial

Recruiting
  • Familial Hypercholesterolemia
  • +7 more
  • Research-based genetic test for Familial Hypercholesterolemia
  • Vancouver, British Columbia, Canada
  • +1 more
Jan 31, 2022

Heterozygous Familial Hypercholesterolemia, Atherosclerotic Cardiovascular Disease, Hypercholesterolemia Trial in Auckland,

Recruiting
  • Heterozygous Familial Hypercholesterolemia
  • +2 more
  • Auckland, New Zealand
  • +1 more
Aug 4, 2022

Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)

Not yet recruiting
  • Dyslipidemias
  • +4 more
  • Combination Therapy
  • +5 more
  • (no location specified)
Aug 22, 2023

Heterozygous Familial Hypercholesterolemia Trial in Beijing (Ongericimab, Placebo)

Recruiting
  • Heterozygous Familial Hypercholesterolemia
  • Ongericimab
  • Placebo
  • Beijing, Beijing, China
    Beijing Anzhen Hospital Capital Medical University City:Beijing
Apr 12, 2022

Diet Quality and Coronary Artery Calcification in Heterozygous

Recruiting
  • Hypercholesterolemia, Familial
  • +2 more
  • Diet
  • Québec, Canada
    Institute of nutrition and functional foods, Laval University
Apr 22, 2022

Heterozygous or Homozygous Familial Hypercholesterolemia Trial (Inclisiran)

Not yet recruiting
  • Heterozygous or Homozygous Familial Hypercholesterolemia
  • (no location specified)
Dec 27, 2022

l Gene Editing Therapy for Cardiovascular Disease

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease
  • +2 more
    • Auckland, New Zealand
    • +2 more
    Oct 31, 2023

    Familial Hypercholesterolemia, Nutrition, Healthy, Cholesterol, Elevated Trial in Québec (Canada's Food Guide principles (CFG

    Recruiting
    • Familial Hypercholesterolemia
    • +4 more
    • Canada's Food Guide principles (CFG diet)
    • Standard North American diet (NAD diet)
    • Québec, Canada
      Institute on nutrition and functional foods, Laval University
    Jan 10, 2022

    Efficacy and Safety, Heterozygous Familial Hypercholesterolemia, PCSK9 Trial in Shenzhen (protein convertase subtilisin/kexin

    Active, not recruiting
    • Efficacy and Safety
    • +2 more
    • protein convertase subtilisin/kexin type 9 inhibitor
    • Shenzhen, Guangdong, China
      xili People's Hospital
    Aug 24, 2021

    Hypercholesterolemia Trial in Saint Louis (Bempedoic acid)

    Recruiting
    • Hypercholesterolemia
    • Bempedoic acid
    • Saint Louis, Missouri
      Washington University School of Medicine, Division of Endocrinol
    Jan 12, 2023

    Heterozygous Familial Hypercholesterolemia Trial in Worldwide (lerodalcibep)

    Active, not recruiting
    • Heterozygous Familial Hypercholesterolemia
    • Cincinnati, Ohio
    • +6 more
    Nov 3, 2022

    Hypercholesterolemia, Heterozygous Familial Hypercholesterolemia Trial (EZ 10 mg/Atorva 20 mg FDC, EZ 10 mg/Atorva 10 mg FDC)

    Completed
    Has Results
    • Hypercholesterolemia
    • Heterozygous Familial Hypercholesterolemia
    • EZ 10 mg/Atorva 20 mg FDC
    • EZ 10 mg/Atorva 10 mg FDC
    • (no location specified)
    Feb 7, 2022

    Pediatric Heterozygous Hypercholesterolemia Trial in Quebec, Athens, Oslo (Atorvastatin)

    Completed
    Has Results
    • Pediatric Heterozygous Hypercholesterolemia
    • Quebec, Canada
    • +2 more
    Feb 17, 2021

    Atherosclerosis, Hypercholesterolemia, Hyperlipoproteinemia Type II Trial (ezetimibe (plus simvastatin), (plus simvastatin))

    Completed
    • Atherosclerosis
    • +2 more
    • ezetimibe (plus simvastatin)
    • placebo (plus simvastatin)
    • (no location specified)
    Feb 7, 2022

    Familial Hypercholesterolemia - Heterozygous Trial in Worldwide (Inclisiran, Placebo)

    Recruiting
    • Familial Hypercholesterolemia - Heterozygous
    • Tucson, Arizona
    • +76 more
    Aug 8, 2022

    Hypercholesterolemia, Familial Trial (Evolocumab, Placebo)

    Completed
    Has Results
    • Hypercholesterolemia, Familial
    • Evolocumab
    • Placebo
    • (no location specified)
    Jan 4, 2021

    Heterozygous Familial Hypercholesterolemia Trial in Beijing (IBI306, )

    Active, not recruiting
    • Heterozygous Familial Hypercholesterolemia
    • Beijing, China
      Beijing Anzhen Hospital， Capital Medical University
    Jan 27, 2021

    Familial Hypercholesterolemia Trial

    Not yet recruiting
    • Familial Hypercholesterolemia
      • (no location specified)
      Apr 11, 2023

      Familial Hypercholesterolemia Trial in Worldwide (Evolocumab)

      Completed
      Has Results
      • Familial Hypercholesterolemia
      • Evolocumab
      • Bronx, New York
      • +45 more
      Dec 16, 2021

      Early Detection of Familial Hypercholesterolemia in Children

      Recruiting
      • Familial Hypercholesterolemia
      • +2 more
      • lifestyle assessment
      • Reus, Tarragona, Spain
      • +1 more
      Apr 29, 2020

      Homozygous Familial Hypercholesterolemia Trial (SHR-1918)

      Not yet recruiting
      • Homozygous Familial Hypercholesterolemia
      • (no location specified)
      Aug 22, 2023

      Homozygous Familial Hypercholesterolemia Trial in Xi'an (NGGT006)

      Not yet recruiting
      • Homozygous Familial Hypercholesterolemia
      • NGGT006
      • Xi'an, Shaanxi, China
        First Affiliated Hospital of Xian Jiaotong University
      Nov 5, 2023